Evidence map›Paper›PMID 41937421›Full record

ArticleInternal medicine journal2026

Prescription and use of ward-delivered nasal high-flow oxygen and non-invasive ventilation for people with acute respiratory failure.

Aiden Cushnahan, Amelia Harrison, Catherine Buchan, Matthew T Naughton, Eli Dabscheck, Natasha Smallwood

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aiden CushnahanDepartment of Respiratory Medicine, The Alfred, Melbourne, Victoria, Australia.ORCID https://orcid.org/0009-0000-1707-5488
Amelia HarrisonDepartment of Respiratory Medicine, The Alfred, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-0368-0841
Catherine BuchanDepartment of Respiratory Medicine, The Alfred, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-4071-2187
Matthew T NaughtonDepartment of Respiratory Medicine, The Alfred, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-2734-0841
Eli DabscheckDepartment of Respiratory Medicine, The Alfred, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-6335-002X
Natasha SmallwoodDepartment of Respiratory Medicine, The Alfred, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-3403-3586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasal high-flow therapy with oxygen entrained (HFNO) and non-invasive ventilation (NIV) are important therapies for managing acute respiratory failure (ARF) in the ward-based setting. The European Respiratory Society released guidelines in 2022 recommending the use of HFNO over conventional oxygen therapy and NIV in patients with hypoxic ARF. We conducted a 12-month retrospective audit of ward-based HFNO and NIV use at our hospital to determine prescribing practices for these therapies and to assist with the safe implementation of the recent European Respiratory Society guidelines. We found significant variation in prescribing practices for both HFNO and NIV.

Indexed as

Noninvasive VentilationOxygen Inhalation TherapyRespiratory InsufficiencyAcute DiseaseFemaleHumansRetrospective Studiesacute respiratory failurenasal high flow oxygen therapynon‐invasive ventilation

Identifiers

PMID41937421
PMCPMC13193442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.